Milena Pantic
Hat mitgewirkt an:
-
Telomerase-Inhibition und Telomer-Dysfunktion in Tumorzellen
-
Impact of the injection site on growth characteristics, phenotype and sensitivity towards cytarabine of twenty acute leukaemia patient-derived xenograft models
-
The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells
-
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics